On the contrary, administration of ganciclovir to transgenic mice expressing thymidine kinase under the CD11b promoter reduced the CD11b+ population and contributed to 30% of tumour increase in the GBM syngeneic GL261 mouse model [47]. The gene discussed is ITGAM; the disease is neoplasm.